Insights

Not Just a Number: Two Sisters’ Journey From Both Sides of Clinical Trials

2015 Sustainability Report

2016 Sustainability Fact Sheet

2016 Sustainability Report

Sustainability Policy

2017 Sustainability Fact Sheet

2018 Sustainability Report

Pharmacokinetic Characteristics of Intranasal Administration of Oxycodone ARIR

Abuse of prescription opioids continues to be a serious public health concern, with as many as 12.5 million individuals aged 12 or older reporting…

Opportunities in low-level radiocarbon microtracing: applications and new technology

14C-radiolabeled (radiocarbon) drug studies are central to defining the disposition of therapeutics in clinical development. Concerns over radiation,…

Predicting Screen Failure Rates of Human Abuse Potential Studies

Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…